Author:
Biancolella Michela,Valentini Alessandra,Minella Daniela,Vecchione Lucia,D’Amico Franca,Chillemi Giovanni,Gravina Paolo,Bueno Susana,Prosperini Gianluca,Desideri Alessandro,Federici Giorgio,Bernardini Sergio,Novelli Giuseppe
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference29 articles.
1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66
2. Isaacs JT (1999) The biology of hormone refractory prostate cancer: Why does it develop? Urol Clin North Am 26:263–273
3. Zhu YS, Katz MD, Imperato-McGinley J (1998) Natural potent androgens: lessons from human genetic models. Baillieres Clin Endocrinol Metab 12:83–113
4. Partin A, Rodriguez R (2002) The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. In: Walsh PC (ed) Campbell’s urology, 8th edn. Saunders, Philadelphia, pp 1237–1296
5. Grossmann ME, Huang H, Tindall DJ (2001) Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 93:1687–1697
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献